NEW YORK, Oct. 20, 2016 /PRNewswire/ -- Future Market Insights (FMI) offers a 10-year forecast of the Indiahemostat market between 2015 and 2025. In terms of value, the market is expected to register a CAGR of 5.8% over the forecast period. This study demonstrates market dynamics and trends that influence the current environment and future status of the hemostat
Hemostat products are used in surgeries and trauma cases for preventing extensive blood loss. The two basic types of products are mechanical and flowable types. The mechanical type comprises sponges, gauzes, strips, films, while flowable type includes powder base. Mechanical hemostats are preferred more by surgeons and medical practitioner due to these products are ready to use and are manufactured in regular intervals. Currently in India the usage of hemostat products is less due to lack of awareness, high pricing and low adoption rate. However, India hemostat market is projected to register a healthy CAGR of 5.8% during the forecast period owing to factors such as benefits offered by these products and creating product image of hemostat among key opinion leaders such as healthcare professionals. Moreover, increasing number of accidents and trauma injuries is expected to drive growth of the India hemostat market during the forecast period. This report assesses trends driving growth of each segment in the market, and offers potential takeaways and strategic recommendations for manufacturers seeking to enter the market.
The hemostat market is segmented as follows:By product typeBy product material baseBy applicationBy distribution channel This report covers the India hemostat market and various segments in terms of revenue contribution. The report also includes FMI's analysis of key trends, drivers, restraints and opportunities that are influencing growth of the India hemostat market. Impact analysis of key growth drivers and restraints is included in this report to better equip clients with crystal-clear decision-making insights.The hemostat market is segmented based on product type, product material base, applications and distribution. Based on product type, the market has been segmented into mechanical product type and flowable product type. The mechanical type segment is expected to register a CAGR of 6.0% during the forecast period. Flowable type segment is expected to witness a decline in market share in terms of revenue from 11.7% in 2015 to 10.1% in 2025. Overpriced products is expected to affect demand for hemostat products over the forecast period. Basically there are two product material base; gelatin base and oxidised cellulose base, gelatin base comprises of 77.0% market share of hemostat market in India owing to maximum usage of gelatin in all hemostat products as it has property of absorbing blood flow at a faster speed and healing the wound. Furthermore hemostat products are segmented into application, surgeries and trauma cases. Surgery segment is expected to witness a decline in market share in terms of revenue from 63.7% in 2015 to 61.8% in 2025. The trauma cases segment is expected to expand at the highest CAGR of 6.3% over the forecast period.The market has also been segmented by distribution channel into hospitals, ambulatory surgical centres, clinics and online channels. The hospitals segment followed by ambulatory surgical centres is expected to account for the highest demand for hemostat products over the forecast period, registering a CAGR of 7.0% and 5.7%. Due to reimbursement for surgeries by insurance payers and increased in adoption of hemostat products by medical practitioners and surgeons. To reach out to the consumers and healthcare professionals manufacturers are supplying products through E-Commerce which is expected to push demand for hemostat products in the online channel over the forecast period.Furthermore, Future Market Insights has developed market attractiveness index for all four segments: product type, product base, application and distribution channel segments. This index helps in identifying the real opportunities in the market.
Last section of the report comprises of competitive landscape of the hemostat market is included with a dashboard view, based on categories of providers, their product portfolio and key differentiators. The key categories providers covered in the report are manufacturers of mechanical and flowable product type. This section gives a detailed comparative analysis of potential vendors in market, key strategies, key differentiators and detailed strength, weakness, opportunity and threat analysis. Also key developments of companies in area of hemostat market, competitor's product USP and market presence in hemostat market. In-depth analysis of capabilities and successes in the hemostat market.Key market players covered in this report are Johnson and Johnson (Ethicon), Baxter, Aegis Lifesciences, Eucare Pharmaceuticals and Mil Laboratories. Major players are focusing on enhancing their regional presence through strategic mergers & acquisitions and by expanding operations.Segmentation on basis of Product TypeMechanical typeFlowable typeSegmentation on basis of Product Material BaseGelatinOxidized celluloseSegmentation on basis of ApplicationSurgeryTrauma casesSegmentation on basis of Distribution ChannelHospitalsAmbulatory Surgical CentersClinicsOnline ChannelsSegmentation on basis of GeographyIndiaRead the full report: http://www.reportlinker.com/p03916526-summary/view-report.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com__________________________Contact Clare: [email protected]US: (339)-368-6001Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hemostat-market-india-industry-analysis-and-opportunity-assessment-2016---2025-300348981.html
Subscribe to our Free Newsletters!
Opportunistic infections are microbial infections that can cause disease in persons with a weak ...
The state health insurance programs provide health care support to the below poverty line (BPL) ...
There is a lining between the lungs and chest wall known as Pleura. The dismissal of pleura by a ...View All